celularity.com (CELU) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Celularity Inc. (CELU) is implementing unique methods for isolating placental stem cells to treat oncology and Crohn's disease without the need for donor searches. This price chart demonstrates an EV/EBITDA of 0.00, accounting for the costs of cryogenic transportation of biologics. Business stability is ensured by a staff of leading biologists, whose commitment is secured through a stock option program and the strategic hiring of experts.
celularity.com - analytical breakdowns and key metrics (CELU)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
CELU - Company Net Income|Future Profit Celularity Inc.|CELU - P/E Multiple|Future Price to Earnings Celularity|CELU - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Celularity Inc.|CELU - Operating profit EBITDA|Earnings per share for the last twelve months Celularity|CELU - Earnings per share for the trailing year|Quarterly EPS earnings growth celularity.com|CELU - Expected net earnings per share growth this year|Expected earnings per share growth for next year Celularity Inc.
Initial company analysis:Celularity Corp CELU
For regenerative medicine pioneer Celularity Inc. (CELU), the EV/EBITDA multiple trend reflects the market valuation of cell therapy potential while accounting for debt load. This indicator compares the total enterprise value with operating profit before depreciation and amortization, allowing investors to assess the real value of assets relative to generated cash flow amidst capital-intensive innovative developments.
Competitors of Celularity Inc. (CELU)
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Dianthus Corp (DNTH) - Enterprise Value to EBITDA Ratio|PHVS: EV/EBITDA Multiple|Company Value to EBITDA AbCellera (ABCL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PGEN|Enterprise Value to EBITDA Ratio PHAR (Pharming)|EV/EBITDA Multiple Nektar Corp (NKTR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|zenasbio.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Immunome - EV/EBITDA Multiple|GOSS - EV/EBITDA Multiple|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Septerna Pharma - Business Value to Operating Income Before Depreciation|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|savarapharma.com (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio RIGL (Rigel Pharmaceuticals, Inc.)|Enterprise Value to Operating Income Before Depreciation Ratio ANAB|Astria Pharma - Enterprise Value to EBITDA Ratio|enGene Corp (ENGN) - Company Value to EBITDA|RAPT: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation JBIO (Aerovate Therapeutics Inc)|ACRS: EV/EBITDA Multiple|KYTX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tiziana Life Sciences PLC|Enterprise Value to Operating Income Before Depreciation CABA (Cabaletta Bio Inc)|EV/EBITDA Multiple VTYX|Enterprise Value to EBITDA Ratio theratech.com THTX|Avalo Therapeutics - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Eledon Pharmaceuticals Inc. (ELDN)|Agenus Inc - EV/EBITDA Multiple|Climb Bio, Inc (CLYM) - Enterprise Value to EBITDA Ratio|ZURA: EV/EBITDA Multiple|Company Value to EBITDA atyrpharma.com (ATYR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adagene Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMA|Enterprise Value to EBITDA Ratio STTK (Shattuck Labs, Inc.)|EV/EBITDA Multiple equilliumbio.com (EQ)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|IMUX (Immunic Therapeutics) - Company Value to Operating Income Before Depreciation Ratio|Atara Biotherapeutics Inc - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation IFRX (InflaRx N.V.)|XFOR: EV/EBITDA Multiple|Adicet Bio, Inc. (ACET) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|BRNS: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to EBITDA Ratio SAB Biotherapeutics Inc. SABS|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|QTTB: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GOVX (geovax.com)|EDSA: EV/EBITDA Multiple|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|Enterprise Value to EBITDA Ratio hcwbiologics.com HCWB|Aptevo Therapeutics Inc. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple aimimmuno.com AIM|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI (GRI Bio Corporation) - Enterprise Value to Operating Income Before Depreciation|XRTX: EV/EBITDA Multiple|Company Value to EBITDA reshapelifesciences.com (HIND)|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Indaptus Therapeutics Inc (INDP)|EV/EBITDA Multiple SCNI|CALI - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|Allakos Inc - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HOOK: Enterprise Value to EBITDA Ratio|IGMS - EV/EBITDA Multiple|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|OCEA (Ocean Biomedical Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TCBP (TC Biopharm) - EV/EBITDA Multiple|EV/EBITDA Multiple thirdharmonicbio.com
